TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 337466

Group type: EXPERIMENTAL
Intervention: Osmic acid treatment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 7304486

Group type: EXPERIMENTAL
Intervention: Bengal gram dal (50 g carbohydrate)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rajmah (50 g carbohydrate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Wheat (50 g carbohydrate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Rice (50 g carbohydrate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Dextrose (50 g carbohydrate)
Number of subjects: 6
Study: 30979672

Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 69
Study: 28699136

Group type: EXPERIMENTAL
Intervention: Intrawound vancomycin
Number of subjects: 380

Group type: COMPARATOR
Intervention: No intrawound vancomycin (Control)
Number of subjects: 380
Study: 27431238

Group type: EXPERIMENTAL
Intervention: GSK2330672 for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK2330672
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24401239

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day) + POMx (1g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Simvastatin (20 mg/day) + placebo
Number of subjects: 23
Study: 22677306

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium 25 mg liquid capsule
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diclofenac potassium 2 x 12.5 mg tablets
Number of subjects: 42
Study: 19730107

Group type: EXPERIMENTAL
Intervention: Bifidobacterium+FOS
Number of subjects: 125

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 125
Study: 18584249

Group type: EXPERIMENTAL
Intervention: Mosapride (15 mg by mouth with 50 ml of water three times a day starting on postoperative day 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (50 ml of water three times a day starting on postoperative day 1)
Number of subjects: 40
Study: 15778565

Group type: EXPERIMENTAL
Intervention: Abdominal meridian massage
Number of subjects: 31

Group type: COMPARATOR
Intervention: No massage (Control)
Number of subjects: 31
Study: 12204702

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost
Number of subjects: 532
Study: 10496192

Group type: EXPERIMENTAL
Intervention: Vesnarinone 30 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vesnarinone 60 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vesnarinone (30 mg or 60 mg)
Number of subjects: 0
Study: 8929752

Group type: EXPERIMENTAL
Intervention: ketamine 6.0 mg/kg j.i.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ketamine 3.5 mg/kg j.i.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ketamine 2.5 mg/kg j.i.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 1798280

Group type: EXPERIMENTAL
Intervention: Recombinant human superoxide dismutase (h‐SOD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6624506

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29750571

Group type: EXPERIMENTAL
Intervention: Modified 5-Year-Olds' Index
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS)
Number of subjects: 351
Study: 30400188

Group type: EXPERIMENTAL
Intervention: QADM composites (10% by mass of bis(2‐methacryloyloxyethyl) dimethylammonium bromide)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control composite without QADM
Number of subjects: 17
Study: 27492789

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate (MPH)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 mg propranolol (PRO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 60
Study: 24875077

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 60 mg 4 times a day
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo 4 times a day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Clonidine 0.075 mg 4 times a day
Number of subjects: 65
Study: 22538793

Group type: EXPERIMENTAL
Intervention: Initial case management (comprehensive, individual advice about available treatment possibilities for dementia patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 0
Study: 21030903

Group type: EXPERIMENTAL
Intervention: 200 days of valganciclovir prophylaxis
Number of subjects: 318

Group type: COMPARATOR
Intervention: 100 days of valganciclovir prophylaxis
Number of subjects: 318
Study: 17259503

Group type: EXPERIMENTAL
Intervention: IFG6.1
Number of subjects: 1428

Group type: EXPERIMENTAL
Intervention: IFG5.6
Number of subjects: 1428
Study: 16142248

Group type: EXPERIMENTAL
Intervention: 123I-ioflupane radiopharmaceutical injected intravenously at a dose of 185 MBq
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal volunteers (control group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Molecular imaging (SPET) with 123I-ioflupane
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Follow-up after eight months
Number of subjects: 54
Study: 14571125

Group type: EXPERIMENTAL
Intervention: Simultaneous erosion and abrasion (toothbrushing with silica abrasive in citric acid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternating erosion and abrasion (brushing with silica abrasive after citric acid exposure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erosion alone (exposure to citric acid without brushing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brushing with silica abrasive after erosion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brushing without abrasive after erosion
Number of subjects: 0
Study: 10360450

Group type: EXPERIMENTAL
Intervention: Capsaicin (100 ml 1 mmol/l)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiological saline (100 ml)
Number of subjects: 12
Study: 8997938

Group type: EXPERIMENTAL
Intervention: Year-long nursing trial guided by the McGill Model of Nursing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engagement with the nurse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Features of the nursing
Number of subjects: 0
Study: 1786502

Group type: EXPERIMENTAL
Intervention: Sensory stimulation protocol
Number of subjects: 4

Group type: COMPARATOR
Intervention: Pre-stimulation measures
Number of subjects: 4

Group type: COMPARATOR
Intervention: Post-stimulation measures
Number of subjects: 4
Study: 7353334

Group type: EXPERIMENTAL
Intervention: Aspirin 975 mg every 6 hr, started 22 hr before phenytoin dose and continued for 48 hr
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (phenytoin alone)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aspirin 975 mg every 6 hr
Number of subjects: 6
Study: 29981804

Group type: EXPERIMENTAL
Intervention: Attentional bias modification training (attended to images of low-calorie food)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (attended equally to images of high- and low-calorie food)
Number of subjects: 65
Study: 27624608

Group type: EXPERIMENTAL
Intervention: Web-based parenting intervention (Triple P Online)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 52
Study: 24385328

Group type: EXPERIMENTAL
Intervention: Hypervolemic patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fluid status (FO) and CNR
Number of subjects: 60
Study: 22742885

Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate (LC)
Number of subjects: 1000
Study: 20460548

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg/d)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19048025

Group type: EXPERIMENTAL
Intervention: Fractional dose 1/5 of the meningococcal polysaccharide vaccine
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Fractional dose 1/10 of the meningococcal polysaccharide vaccine
Number of subjects: 750

Group type: COMPARATOR
Intervention: Full dose of the meningococcal polysaccharide vaccine
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Fractional doses (1/5 and 1/10) of the meningococcal polysaccharide vaccine
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: All doses of the meningococcal polysaccharide vaccine
Number of subjects: 750
Study: 15651055

Group type: EXPERIMENTAL
Intervention: Taking CHARGE intervention
Number of subjects: 25
Study: 12464757

Group type: EXPERIMENTAL
Intervention: Sucrose and nonnutritive sucking
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Sucrose alone
Number of subjects: 190

Group type: COMPARATOR
Intervention: Sterile water and nonnutritive sucking (control)
Number of subjects: 190
Study: 10367299

Group type: EXPERIMENTAL
Intervention: Organized breast cancer screening
Number of subjects: 500

Group type: COMPARATOR
Intervention: Personal invitation letter
Number of subjects: 500

Group type: COMPARATOR
Intervention: Preliminary visit to the GP
Number of subjects: 500

Group type: COMPARATOR
Intervention: Examination outside business hours
Number of subjects: 500
Study: 8575589

Group type: EXPERIMENTAL
Intervention: Aerosol administration of antipseudomonal antibiotics
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (nebulized solution)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aerosol administration of antipseudomonal antibiotics as adjunct to intravenous therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aerosol maintenance treatment with appropriate antibiotic in high enough dosage
Number of subjects: 12
Study: 1781229

Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 99

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 99
Study: 6109855

Group type: EXPERIMENTAL
Intervention: Thrice-weekly isoniazid, rifampicin, streptomycin, and ethambutol (without pyrazinamide)
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Thrice-weekly isoniazid, rifampicin, streptomycin, and pyrazinamide
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Thrice-weekly isoniazid, rifampicin, pyrazinamide, and ethambutol
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Thrice-weekly isoniazid, rifampicin, pyrazinamide, and streptomycin
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Daily isoniazid, rifampicin, pyrazinamide, and ethambutol
Number of subjects: 971
Study: 31397120

Group type: COMPARATOR
Intervention: Intratracheal administration of corticosteroids (IAC)
Number of subjects: 1515
Study: 28255756

Group type: EXPERIMENTAL
Intervention: Psychosocial coaching intervention (5 coaching sessions plus physiotherapy)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Physiotherapy alone (control group)
Number of subjects: 68
Study: 25746670

Group type: EXPERIMENTAL
Intervention: 24 or 60 weeks of combination antiretroviral therapy (cART)
Number of subjects: 47

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 47
Study: 23917585

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (100 mg) or streptokinase (1,500,000 U)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Reperfused group
Number of subjects: 168

Group type: COMPARATOR
Intervention: Nonreperfused group
Number of subjects: 168
Study: 21712241

Group type: EXPERIMENTAL
Intervention: Raltegravir-based regimen (immediate group)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Raltegravir-based regimen (deferred group)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Raltegravir and ritonavir‐boosted tipranavir
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 170

Group type: COMPARATOR
Intervention: Enfuvirtide-based regimen (maintenance arm)
Number of subjects: 170
Study: 19187327

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Allergen challenge
Number of subjects: 16

Group type: COMPARATOR
Intervention: AMP challenge
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both AMP and allergen challenges
Number of subjects: 16
Study: 16682305

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter‐defibrillator (ICD) therapy
Number of subjects: 951

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 951
Study: 14745142

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11215366

Group type: EXPERIMENTAL
Intervention: Human albumin (5-8 g/l ascites)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Reinfusion of ascitic-ultrafiltrate fluid by means of hemofiltration technique
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Human albumin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Reinfusion of ascitic-ultrafiltrate fluid
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 18476179

Group type: EXPERIMENTAL
Intervention: Ampicillin/Sulbactam (2 g/1 g, IV every 6 h)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cefoxitin (2 g, IV every 6 h)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ampicillin/Sulbactam
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 93
Study: 7792559

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single dose)
Number of subjects: 551

Group type: COMPARATOR
Intervention: Cefuroxime (thrice daily until the end of the second postoperative day)
Number of subjects: 551

Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 551
Study: 2509267

Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30362876

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical spinal stimulation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study: 25910473

Group type: EXPERIMENTAL
Intervention: Naloxone Auto-Injector (NAI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Naloxone Intranasal Delivery System (NXN)
Number of subjects: 42
Study: 23834117

Group type: EXPERIMENTAL
Intervention: NB‐UVB phototherapy
Number of subjects: 322

Group type: COMPARATOR
Intervention: ETN 50 mg twice weekly
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Combination of NB‐UVB phototherapy and ETN
Number of subjects: 322
Study: 21538218

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (pulsed infrared laser) and exercise therapy for ten sessions over 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo laser and exercise therapy for ten sessions over 2 weeks
Number of subjects: 80
Study: 18344556

Group type: EXPERIMENTAL
Intervention: Xenon
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 17162891

Group type: EXPERIMENTAL
Intervention: Acrysof SA60AT IOL
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Sensar AR40e IOL
Number of subjects: 117
Study: 14592919

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10750290

Group type: EXPERIMENTAL
Intervention: Bladder filled with 300 ml
Number of subjects: 20

Group type: COMPARATOR
Intervention: Empty bladder
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bladder filled with 200 ml
Number of subjects: 20
Study: 8777274

Group type: EXPERIMENTAL
Intervention: 100 ng LPS/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High HDL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium doses of LPS (100 ng/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of LPS (1 ng/ml)
Number of subjects: 0
Study: 2050425

Group type: EXPERIMENTAL
Intervention: 1 g cefodizime
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2 g cefodizime
Number of subjects: 50
Study: 6342956

Group type: EXPERIMENTAL
Intervention: 100 mg sodium meclofenamate 3-times daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 250 mg naproxen twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both treatment groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: sodium meclofenamate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 40
Study: 30528951

Group type: EXPERIMENTAL
Intervention: Diet P high polyunsaturated (PUFAs) fat hypocaloric diet
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Diet M high monounsaturated (MUFAs) fat hypocaloric diet
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group (A allele carriers)
Number of subjects: 362
Study: 27693237

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (3 sessions)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (5 sessions)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo tDCS
Number of subjects: 28
Study: 26520158

Group type: EXPERIMENTAL
Intervention: Reach Out and Read program (ROaR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 30
Study: 26466438

Group type: EXPERIMENTAL
Intervention: Restorative resin-based composite with various polishing regimes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (patients without diabetes mellitus)
Number of subjects: 30
Study: 22829919

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine (SP)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Controls (sulfadoxine-pyrimethamine twice)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine (SP) among HIV-negative participants
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP) among HIV-negative participants
Number of subjects: 484
Study: 19605964

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (straight laparoscopic surgery in 92 patients and hand-assisted laparoscopic surgery in 38 patients)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 130
Study: 18089908

Group type: EXPERIMENTAL
Intervention: Training (aerobic and strength exercises)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nontraining
Number of subjects: 16
Study: 15149550

Group type: EXPERIMENTAL
Intervention: Experienced endoscopists
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inexperienced endoscopists
Number of subjects: 10
Study: 11672499

Group type: EXPERIMENTAL
Intervention: Smoke + Distractor
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Smoke + No Distractor
Number of subjects: 45

Group type: COMPARATOR
Intervention: No Smoke + Distractor
Number of subjects: 45

Group type: COMPARATOR
Intervention: No Smoke + No Distractor
Number of subjects: 45
Study: 9540427

Group type: EXPERIMENTAL
Intervention: Iloprost 25 micrograms
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Iloprost 50 micrograms
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Iloprost 75 micrograms
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Iloprost 100 micrograms
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 302
Study: 9329511

Group type: COMPARATOR
Intervention: Naproxen (750 mg daily for 8 weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Triple therapy (bismuth subcitrate 120 mg, tetracycline 500 mg, metronidazole 400 mg, each given orally four times daily for 1 week) followed by naproxen (750 mg daily for 8 weeks)
Number of subjects: 100
Study: 2663937

Group type: EXPERIMENTAL
Intervention: Topical ketanserin (2% ointment)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 194691

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (cyclophosphamide, methotrexate, CCNU)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard-dose chemotherapy (cyclophosphamide, methotrexate, CCNU)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 32
Study: 31743533

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine 0.25 mg/kg preoperatively, followed by 0.25 mg/kg/hr intraoperatively, and 0.1 mg/kg/hr from 1 hr before the end of surgery until the end of recovery room stay
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 31422685

Group type: EXPERIMENTAL
Intervention: Fibrosis homogenization as second procedure for group 1 (AF recurrence)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: LGE‐MRI‐detected scar‐based dechanneling for group 2 (AT recurrence)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Electroanatomically guided dechanneling in group 2
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: LGE‐MRI based dechanneling in group 2
Number of subjects: 102
Study: 27830456

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin Glargine
Number of subjects: 32
Study: 26076867

Group type: EXPERIMENTAL
Intervention: avibactam 500 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ceftazidime 2000 mg plus avibactam 500 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 23260506

Group type: EXPERIMENTAL
Intervention: Physician management plus cognitive behavioral therapy
Number of subjects: 141

Group type: COMPARATOR
Intervention: Physician management
Number of subjects: 141
Study: 22980100

Group type: EXPERIMENTAL
Intervention: Community-based psychosocial intervention consisting of 12 sessions (30 minutes of relaxation exercises and 75 minutes of structured support groups) delivered twice per week over six weeks.
Number of subjects: 0
Study: 19328348

Group type: EXPERIMENTAL
Intervention: Electronystagmography testing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 20
Study: 16452734

Group type: EXPERIMENTAL
Intervention: Reduction and fixation
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty with cement
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Total hip replacement with cement
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 207